Skip to main content

Hirano Patricia C's Form 4 filing

Soleno Therapeutics Inc (SLNO) · filed Mar 31, 2025

Accession no.
0001415889-25-009291
Filed
Mar 31, 2025
Trade date
Mar 27-28, 2025
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 23 non-derivative transactions and 7 derivative transactions. Open-market sales total $10.7M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hirano Patricia CCIK 0001766042Officer (SEE REMARKS)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 27, 2025Common StockSSaleDisposed−1,418$65.97−$93,545.46110,884Direct
Mar 27, 2025Common StockSSaleDisposed−2,310$66.79−$154,284.9108,574Direct
Mar 27, 2025Common StockSSaleDisposed−4,199$67.70−$284,272.3104,375Direct
Mar 27, 2025Common StockSSaleDisposed−5,524$68.79−$379,995.9698,851Direct
Mar 27, 2025Common StockSSaleDisposed−3,198$69.84−$223,348.3295,653Direct
Mar 27, 2025Common StockSSaleDisposed−329$70.73−$23,270.1795,324Direct
Mar 27, 2025Common StockSSaleDisposed−478$71.74−$34,291.7294,846Direct
Mar 27, 2025Common StockSSaleDisposed−73$72.64−$5,302.7294,773Direct
Mar 27, 2025Common StockMOption exerciseAcquired+6,000$24.00+$144,000100,773Direct
Mar 27, 2025Common StockMOption exerciseAcquired+4,400$25.05+$110,220105,173Direct
Mar 27, 2025Common StockMOption exerciseAcquired+4,888$5.10+$24,928.8110,061Direct
Mar 27, 2025Common StockMOption exerciseAcquired+13,333$2.60+$34,665.8123,394Direct
Mar 27, 2025Common StockMOption exerciseAcquired+8,333$2.41+$20,082.53131,727Direct
Mar 27, 2025Common StockMOption exerciseAcquired+35,186$5.25+$184,726.5166,913Direct
Mar 27, 2025Common StockSSaleDisposed−46,214$66.39−$3,068,147.46120,699Direct
Mar 27, 2025Common StockSSaleDisposed−24,776$67.47−$1,671,636.7295,923Direct
Mar 27, 2025Common StockSSaleDisposed−24,989$70.18−$1,753,728.0270,934Direct
Mar 27, 2025Common StockSSaleDisposed−15,145$72.50−$1,098,012.555,789Direct
Mar 28, 2025Common StockMOption exerciseAcquired+2,691$33.60+$90,417.658,480Direct
Mar 28, 2025Common StockSSaleDisposed−3,394$67.46−$228,959.2455,086Direct
Mar 28, 2025Common StockSSaleDisposed−12,324$68.92−$849,370.0842,762Direct
Mar 28, 2025Common StockSSaleDisposed−9,253$69.52−$643,268.5633,509Direct
Mar 28, 2025Common StockSSaleDisposed−2,691$73.60−$198,057.630,818Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 27, 2025Common StockMOption exerciseDisposed−6,000$0.00$00Direct
Mar 27, 2025Common StockMOption exerciseDisposed−4,400$0.00$00Direct
Mar 27, 2025Common StockMOption exerciseDisposed−4,888$0.00$02,445Direct
Mar 27, 2025Common StockMOption exerciseDisposed−13,333$0.00$00Direct
Mar 27, 2025Common StockMOption exerciseDisposed−8,333$0.00$011,667Direct
Mar 27, 2025Common StockMOption exerciseDisposed−35,186$0.00$049,262Direct
Mar 28, 2025Common StockMOption exerciseDisposed−2,691$0.00$018,842Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)